Clinical Trial: Using Apollo Neuro in Autistic Children With Self-Injurious Behavior

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07648420) titled 'Using Apollo Neuro in Autistic Children With Self-Injurious Behavior' on June 09.

Brief Summary: This study will evaluate the feasibility and acceptability of the Apollo Neuro, a wearable vibrotactile sensory device, in autistic children who engage in self-injurious behavior (SIB).

Participants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Outcomes will include adherence to device use, caregiver-reported feasibility and acceptability, and descriptive characterization of caregiver-reported self- injurious and repetitive behaviors during the study period. This preliminary, single-gr...